This inventor holds 8 USPTO granted patents and 1 published patent application and 8 EPO patents. Top assignees: Mcbi, Inc., Medical Corporation Sochikai, Shimadzu Corporation. Active years: 2005-2025.
Location History:
- Tsukuba, JP (2005 - 2023)
- Ibaraki, JP (2023)
Company Filing History:
7 out of 8 
1 out of 1 
1 out of 3,687 
Years Active: 2005-2025
Title: Kazuhiko Uchida: Innovator in Cognitive Dysfunction Detection
Introduction
Kazuhiko Uchida is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of cognitive dysfunction detection, holding a total of eight patents. His work focuses on developing biomarkers and methods for identifying cognitive dysfunction diseases.
Latest Patents
Uchida's latest patents include innovative methods for detecting cognitive dysfunction diseases using specific biomarkers. These biomarkers consist of intact proteins such as apolipoprotein A1, transthyretin, and complement C3, which can be measured in biological samples. His cognitive function determination method involves applying sensory stimuli or tasks of varying difficulty to assess changes in brain activity, ultimately determining the cognitive function of the subject.
Career Highlights
Throughout his career, Kazuhiko Uchida has worked with notable companies, including Mcbi, Inc. and Tum Gene, Inc. His expertise in the field has led to advancements in understanding and diagnosing cognitive dysfunction.
Collaborations
Uchida has collaborated with esteemed colleagues, including Kohji Meno and Hideaki Suzuki, to further his research and innovations in cognitive health.
Conclusion
Kazuhiko Uchida's contributions to the detection of cognitive dysfunction diseases through innovative biomarkers and methods highlight his role as a leading inventor in this critical area of research. His work continues to pave the way for advancements in cognitive health diagnostics.